Rocket One (RKTO) Assets Average (2019 - 2026)
Rocket One's (RKTO) quarterly Assets Average came in at $7.6 million in Q2 2026, down 32.43% year-over-year from $11.2 million in Q2 2025, and up 15.01% quarter-over-quarter from $6.6 million in Q1 2026.
Analysis
Rocket One (RKTO) Assets Average (2019 - 2026) Analysis & Trends
Rocket One has disclosed Assets Average across 8 years of filings, most recently posting $7.6 million for Q2 2026.
- In Q2 2026, Assets Average fell 32.43% year-over-year to $7.6 million; the TTM figure through Jun 2026 stood at $7.6 million (down 32.43% YoY), while the FY2025 annual figure was $7.7 million, down 14.7% from the prior year.
- Assets Average came in at $7.6 million for Q2 2026 at Rocket One, up from $6.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $13.6 million in Q2 2023 to a low of $6.6 million in Q1 2026.
- Average Assets Average over 5 years is $10.0 million, with a median of $9.9 million recorded in 2022.
- Year-over-year, Assets Average slumped 45.68% in 2022 and soared 31.23% in 2023.
- Over 5 years, Assets Average stood at $8.8 million in 2022, then soared by 31.23% to $11.6 million in 2023, then decreased by 28.88% to $8.2 million in 2024, then grew by 2.34% to $8.4 million in 2025, then decreased by 9.91% to $7.6 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $7.6 million in Q2 2026, $6.6 million in Q1 2026, and $8.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 7.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.59 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 8.42 Mn |
| Sep 30, 2025 | 9.68 Mn |
| Jun 30, 2025 | 11.23 Mn |
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 8.23 Mn |
| Sep 30, 2024 | 9.66 Mn |
| Jun 30, 2024 | 9.84 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 11.57 Mn |
| Sep 30, 2023 | 12.86 Mn |
| Jun 30, 2023 | 13.61 Mn |
| Mar 31, 2023 | 11.07 Mn |
| Dec 31, 2022 | 8.82 Mn |
| Sep 30, 2022 | 11.07 Mn |
| Jun 30, 2022 | 10.60 Mn |
| Mar 31, 2022 | 9.97 Mn |
| Dec 31, 2021 | 13.09 Mn |
| Sep 30, 2021 | 16.61 Mn |